JCR Pharmaceuticals Co., Ltd.
Notice of Recording Special Income (Grant Income)
Recorded a special income of 1,882 million yen from a grant by the Ministry of Health, Labour and Welfare in the third quarter of the fiscal year ending March 2026.
Key Figures
- Special Income (Grant Income): 1,882 million yen (Recorded in Q3 of fiscal year ending March 2026)
- Grant Target Facility: Kobe Science Park Center (API Factory)
- Accounting Period: October 1, 2025 - December 31, 2025
AI要約
Details of Special Income (Grant Income)
JCR Pharmaceuticals Co., Ltd. recorded special income of 1,882 million yen in the third quarter of the fiscal year ending March 2026, relating to the grant received from the Ministry of Health, Labour and Welfare for the construction of the Kobe Science Park Center (API factory). This amount was determined by deducting the asset retirement amount of fixed assets and unused refundable portions from grants previously received and recorded in a deferred special account.
Impact on Financial Performance
For the impact of this special income on financial results, please refer to the "Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)" announced on the same day.
